HLTH holdings
All 51 lines reported by VanEck for VanEck Global Healthcare Leaders ETF, as at 3 Sept 2026.
| # | Holding | Ticker | Country | Sector | Weight |
|---|---|---|---|---|---|
| 1 | Illumina Inc | ILMN US | United States | 3.26% | |
| 2 | Halozyme Therapeutics Inc | HALO US | United States | 3.13% | |
| 3 | Arrowhead Pharmaceuticals Inc | ARWR US | United States | 2.82% | |
| 4 | Argenx Se | ARGX US | United States | 2.74% | |
| 5 | West Pharmaceutical Services Inc | WST US | United States | 2.65% | |
| 6 | Ypsomed Holding Ag | YPSN SW | Switzerland | 2.60% | |
| 7 | Exelixis Inc | EXEL US | United States | 2.58% | |
| 8 | Dexcom Inc | DXCM US | United States | 2.54% | |
| 9 | Incyte Corp | INCY US | United States | 2.53% | |
| 10 | Merck & Co Inc | MRK US | United States | 2.39% | |
| 11 | Novo Nordisk A/S | NOVOB DC | Denmark | 2.25% | |
| 12 | Teva Pharmaceutical Industries Ltd | TEVA IT | Israel | 2.24% | |
| 13 | Neurocrine Biosciences Inc | NBIX US | United States | 2.21% | |
| 14 | Amgen Inc | AMGN US | United States | 2.20% | |
| 15 | Encompass Health Corp | EHC US | United States | 2.20% | |
| 16 | Vertex Pharmaceuticals Inc | VRTX US | United States | 2.16% | |
| 17 | Eli Lilly & Co | LLY US | United States | 2.14% | |
| 18 | Orion Oyj | ORNBV FH | Finland | 2.14% | |
| 19 | Alteogen Inc | 196170 KS | South Korea | 2.13% | |
| 20 | Fisher & Paykel Healthcare Corp Ltd | FPH NZ | New Zealand | 2.10% | |
| 21 | Bristol-Myers Squibb Co | BMY US | United States | 2.08% | |
| 22 | Johnson & Johnson | JNJ US | United States | 2.07% | |
| 23 | Tenet Healthcare Corp | THC US | United States | 2.07% | |
| 24 | Ipsen Sa | IPN FP | France | 2.03% | |
| 25 | Otsuka Holdings Co Ltd | 4578 JP | Japan | 2.03% | |
| 26 | Daiichi Sankyo Co Ltd | 4568 JP | Japan | 1.87% | |
| 27 | Kyowa Kirin Co Ltd | 4151 JP | Japan | 1.87% | |
| 28 | Samsung Biologics Co Ltd | 207940 KS | South Korea | 1.87% | |
| 29 | Alk-Abello A/S | ALKB DC | Denmark | 1.85% | |
| 30 | Astellas Pharma Inc | 4503 JP | Japan | 1.85% | |
| 31 | Resmed Inc | RMD US | United States | 1.82% | |
| 32 | Penumbra Inc | PEN US | United States | 1.75% | |
| 33 | Sk Biopharmaceuticals Co Ltd | 326030 KS | South Korea | 1.75% | |
| 34 | Globus Medical Inc | GMED US | United States | 1.73% | |
| 35 | Idexx Laboratories Inc | IDXX US | United States | 1.71% | |
| 36 | Gsk Plc | GSK LN | United Kingdom | 1.70% | |
| 37 | Stryker Corp | SYK US | United States | 1.69% | |
| 38 | United Therapeutics Corp | UTHR US | United States | 1.67% | |
| 39 | Ucb Sa | UCB BB | Belgium | 1.63% | |
| 40 | Hoya Corp | 7741 JP | Japan | 1.62% | |
| 41 | Shionogi & Co Ltd | 4507 JP | Japan | 1.60% | |
| 42 | Universal Health Services Inc | UHS US | United States | 1.58% | |
| 43 | Astrazeneca Plc | AZN SS | Sweden | 1.56% | |
| 44 | Alnylam Pharmaceuticals Inc | ALNY US | United States | 1.55% | |
| 45 | Ensign Group Inc/The | ENSG US | United States | 1.50% | |
| 46 | Intuitive Surgical Inc | ISRG US | United States | 1.43% | |
| 47 | Chugai Pharmaceutical Co Ltd | 4519 JP | Japan | 1.33% | |
| 48 | Boston Scientific Corp | BSX US | United States | 1.27% | |
| 49 | Insulet Corp | PODD US | United States | 1.23% | |
| 50 | Zoetis Inc | ZTS US | United States | 1.20% | |
| 51 | Other/Cashcash / derivative | 0.07% |
Weights as reported by the issuer; they sum to 100.0%. Holdings of other ETFs link to that fund.